TAp73 transcriptionally represses BNIP3 expression

References

• Rufini A, Agostini M, Grespi F, Tomasini R, Sayan BS, Niklison-Chirou MV, Conforti F, Velletri T, Mastino A, Mak TW, et al. p73 in Cancer. Genes Cancer 2011; 2:491-502; PMID:21779517; http://dx.doi.org/10.1177/1947601911408890
   PubMedGoogle Scholar
• Engelmann D, Meier C, Alla V, Putzer BM. A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression. Oncogene 2014; 0; PMID:25381823.
   PubMed Web of Science ®Google Scholar
• Grespi F, Amelio I, Tucci P, Annicchiarico-Petruzzelli M, Melino G. Tissue-specific expression of p73 C-terminal isoforms in mice. Cell Cycle 2012; 11:4474-83; PMID:23159862; http://dx.doi.org/10.4161/cc.22787
   PubMed Web of Science ®Google Scholar
• Conforti F, Yang AL, Agostini M, Rufini A, Tucci P, Nicklison-Chirou MV, Grespi F, Velletri T, Knight RA, Melino G, et al. Relative expression of TAp73 and DeltaNp73 isoforms. Aging 2012; 4:202-5; PMID:22388545
   PubMedGoogle Scholar
• Luh LM, Kehrloesser S, Deutsch GB, Gebel J, Coutandin D, Schafer B, Agostini M, Melino G, Dotsch V. Analysis of the oligomeric state and transactivation potential of TAp73alpha. Cell Death Differ 2013; 20:1008-16; PMID:23538419; http://dx.doi.org/10.1038/cdd.2013.23
   PubMed Web of Science ®Google Scholar
• Levine AJ, Oren M. The first 30 years of p53: growing ever more complex. Nat Rev Cancer 2009; 9:749-58; PMID:19776744; http://dx.doi.org/10.1038/nrc2723
   PubMed Web of Science ®Google Scholar
• Belyi VA, Levine AJ. One billion years of p53/p63/p73 evolution. Proc Natl Acad Sci U S A 2009; 106:17609-10; PMID:19826090; http://dx.doi.org/10.1073/pnas.0910634106
   PubMed Web of Science ®Google Scholar
• Levine AJ, Tomasini R, McKeon FD, Mak TW, Melino G. The p53 family: guardians of maternal reproduction. Nat Rev Mol Cell Biol 2011; 12:259-65; PMID:21427767; http://dx.doi.org/10.1038/nrm3086
   PubMed Web of Science ®Google Scholar
• Nair BC, Krishnan SR, Sareddy GR, Mann M, Xu B, Natarajan M, Hasty P, Brann D, Tekmal RR, Vadlamudi RK. Proline, glutamic acid and leucine-rich protein-1 is essential for optimal p53-mediated DNA damage response. Cell Death Differ 2014; 21:1409-18; PMID:24786831; http://dx.doi.org/10.1038/cdd.2014.55
   PubMed Web of Science ®Google Scholar
• Dashzeveg N, Taira N, Lu ZG, Kimura J, Yoshida K. Palmdelphin, a novel target of p53 with Ser46 phosphorylation, controls cell death in response to DNA damage. Cell Death Dis 2014; 5:e1221; PMID:24810057; http://dx.doi.org/10.1038/cddis.2014.176
   PubMed Web of Science ®Google Scholar
• Zambetti GP. Expanding the reach of the p53 tumor suppressor network. Cell Death Differ 2014; 21:505-6; PMID:24608846; http://dx.doi.org/10.1038/cdd.2014.13
   PubMed Web of Science ®Google Scholar
• Zaccara S, Tebaldi T, Pederiva C, Ciribilli Y, Bisio A, Inga A. p53-directed translational control can shape and expand the universe of p53 target genes. Cell Death Differ 2014; 21:1522-34; PMID:24926617; http://dx.doi.org/10.1038/cdd.2014.79
   PubMed Web of Science ®Google Scholar
• Bisio A, Zamborszky J, Zaccara S, Lion M, Tebaldi T, Sharma V, Raimondi I, Alessandrini F, Ciribilli Y, Inga A. Cooperative interactions between p53 and NFkappaB enhance cell plasticity. Oncotarget 2014; 5:12111-25; PMID:25401416
   PubMed Web of Science ®Google Scholar
• Hu W, Feng Z, Teresky AK, Levine AJ. p53 regulates maternal reproduction through LIF. Nature 2007; 450:721-4; PMID:18046411; http://dx.doi.org/10.1038/nature05993
   PubMed Web of Science ®Google Scholar
• Inoue S, Tomasini R, Rufini A, Elia AJ, Agostini M, Amelio I, Cescon D, Dinsdale D, Zhou L, Harris IS, et al. TAp73 is required for spermatogenesis and the maintenance of male fertility. Proc Natl Acad Sci U S A 2014; 111:1843-8; PMID:24449892; http://dx.doi.org/10.1073/pnas.1323416111
   PubMed Web of Science ®Google Scholar
• Suh EK, Yang A, Kettenbach A, Bamberger C, Michaelis AH, Zhu Z, Elvin JA, Bronson RT, Crum CP, McKeon F. p63 protects the female germ line during meiotic arrest. Nature 2006; 444:624-8; PMID:17122775; http://dx.doi.org/10.1038/nature05337
   PubMed Web of Science ®Google Scholar
• Van Nostrand JL, Brady CA, Jung H, Fuentes DR, Kozak MM, Johnson TM, Lin CY, Lin CJ, Swiderski DL, Vogel H, et al. Inappropriate p53 activation during development induces features of CHARGE syndrome. Nature 2014; 514:228-32; PMID:25119037
   PubMed Web of Science ®Google Scholar
• Kang HJ, Feng Z, Sun Y, Atwal G, Murphy ME, Rebbeck TR, Rosenwaks Z, Levine AJ, Hu W. Single-nucleotide polymorphisms in the p53 pathway regulate fertility in humans. Proc Natl Acad Sci U S A 2009; 106:9761-6; PMID:19470478; http://dx.doi.org/10.1073/pnas.0904280106
   PubMed Web of Science ®Google Scholar
• Hu W, Feng Z, Levine AJ. The regulation of human reproduction by p53 and its pathway. Cell Cycle 2009; 8:3621-2; PMID:19884797; http://dx.doi.org/10.4161/cc.8.22.9938
   PubMed Web of Science ®Google Scholar
• Celardo I, Antonov A, Amelio I, Annicchiarico-Petruzzelli M, Melino G. p63 transcriptionally regulates the expression of matrix metallopeptidase 13. Oncotarget 2014; 5:1279-89; PMID:24658133
   PubMed Web of Science ®Google Scholar
• Amelio I, Grespi F, Annicchiarico-Petruzzelli M, Melino G. p63 the guardian of human reproduction. Cell Cycle 2012; 11:4545-51; PMID:23165243; http://dx.doi.org/10.4161/cc.22819
   PubMed Web of Science ®Google Scholar
• Shetzer Y, Kagan S, Koifman G, Sarig R, Kogan-Sakin I, Charni M, Kaufman T, Zapatka M, Molchadsky A, Rivlin N, et al. The onset of p53 loss of heterozygosity is differentially induced in various stem cell types and may involve the loss of either allele. Cell Death Differ 2014; 21:1419-31; PMID:24832469; http://dx.doi.org/10.1038/cdd.2014.57
   PubMed Web of Science ®Google Scholar
• Buckley NE, D'Costa Z, Kaminska M, Mullan PB. S100A2 is a BRCA1/p63 coregulated tumour suppressor gene with roles in the regulation of mutant p53 stability. Cell Death Dis 2014; 5:e1070; PMID:24556685; http://dx.doi.org/10.1038/cddis.2014.31
   PubMed Web of Science ®Google Scholar
• Mello SS, Attardi LD. Not all p53 gain-of-function mutants are created equal. Cell Death Differ 2013; 20:855-7; PMID:23749181; http://dx.doi.org/10.1038/cdd.2013.53
   PubMed Web of Science ®Google Scholar
• Rufini A, Tucci P, Celardo I, Melino G. Senescence and aging: the critical roles of p53. Oncogene 2013; 32:5129-43; PMID:23416979; http://dx.doi.org/10.1038/onc.2012.640
   PubMed Web of Science ®Google Scholar
• Li T, Kon N, Jiang L, Tan M, Ludwig T, Zhao Y, Baer R, Gu W. Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell 2012; 149:1269-83; PMID:22682249; http://dx.doi.org/10.1016/j.cell.2012.04.026
   PubMed Web of Science ®Google Scholar
• Wang J, Qian J, Hu Y, Kong X, Chen H, Shi Q, Jiang L, Wu C, Zou W, Chen Y, et al. ArhGAP30 promotes p53 acetylation and function in colorectal cancer. Nat Commun 2014; 5:4735; PMID:25156493; http://dx.doi.org/10.1038/ncomms5735
   PubMed Web of Science ®Google Scholar
• Li D, Yallowitz A, Ozog L, Marchenko N. A gain-of-function mutant p53-HSF1 feed forward circuit governs adaptation of cancer cells to proteotoxic stress. Cell Death Dis 2014; 5:e1194; PMID:24763051; http://dx.doi.org/10.1038/cddis.2014.158
   PubMed Web of Science ®Google Scholar
• Weilbacher A, Gutekunst M, Oren M, Aulitzky WE, van der Kuip H. RITA can induce cell death in p53-defective cells independently of p53 function via activation of JNK/SAPK and p38. Cell Death Dis 2014; 5:e1318; PMID:25010984; http://dx.doi.org/10.1038/cddis.2014.284
   PubMed Web of Science ®Google Scholar
• Blasius M, Bartek J. ATM targets hnRNPK to control p53. Cell Cycle 2013; 12:1162-3; PMID:23549171; http://dx.doi.org/10.4161/cc.24485
   PubMed Web of Science ®Google Scholar
• Xu J, Wang J, Hu Y, Qian J, Xu B, Chen H, Zou W, Fang JY. Unequal prognostic potentials of p53 gain-of-function mutations in human cancers associate with drug-metabolizing activity. Cell Death Dis 2014; 5:e1108; PMID:24603336; http://dx.doi.org/10.1038/cddis.2014.75
   PubMed Web of Science ®Google Scholar
• Celardo I, Grespi F, Antonov A, Bernassola F, Garabadgiu AV, Melino G, Amelio I. Caspase-1 is a novel target of p63 in tumor suppression. Cell Death Dis 2013; 4:e645; PMID:23703390; http://dx.doi.org/10.1038/cddis.2013.175
   PubMed Web of Science ®Google Scholar
• Guerrieri F, Piconese S, Lacoste C, Schinzari V, Testoni B, Valogne Y, Gerbal-Chaloin S, Samuel D, Brechot C, Faivre J, et al. The sodium/iodide symporter NIS is a transcriptional target of the p53-family members in liver cancer cells. Cell Death Dis 2013; 4:e807; PMID:24052075; http://dx.doi.org/10.1038/cddis.2013.302
   PubMed Web of Science ®Google Scholar
• Del Nagro CJ, Choi J, Xiao Y, Rangell L, Mohan S, Pandita A, Zha J, Jackson PK, O'Brien T. Chk1 inhibition in p53-deficient cell lines drives rapid chromosome fragmentation followed by caspase-independent cell death. Cell Cycle 2014; 13:303-14; PMID:24247149; http://dx.doi.org/10.4161/cc.27055
   PubMed Web of Science ®Google Scholar
• Rufini S, Lena AM, Cadot B, Mele S, Amelio I, Terrinoni A, Desideri A, Melino G, Candi E. The sterile α-motif (SAM) domain of p63 binds in vitro monoasialoganglioside (GM1) micelles. Biochem Pharmacol 2011; 82:1262-8; PMID:21820419; http://dx.doi.org/10.1016/j.bcp.2011.07.087
   PubMed Web of Science ®Google Scholar
• Fan YH, Cheng J, Vasudevan SA, Dou J, Zhang H, Patel RH, Ma IT, Rojas Y, Zhao Y, Yu Y, et al. USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis. Cell Death Dis 2013; 4:e867; PMID:24136231; http://dx.doi.org/10.1038/cddis.2013.400
   PubMed Web of Science ®Google Scholar
• Melino G, De Laurenzi V, Vousden KH. p73: Friend or foe in tumorigenesis. Nat Rev Cancer 2002; 2:605-15; PMID:12154353; http://dx.doi.org/10.1038/nrc861
   PubMed Web of Science ®Google Scholar
• Tomasini R, Mak TW, Melino G. The impact of p53 and p73 on aneuploidy and cancer. Trends Cell Biol 2008; 18:244-52; PMID:18406616; http://dx.doi.org/10.1016/j.tcb.2008.03.003
   PubMed Web of Science ®Google Scholar
• Fatt MP, Cancino GI, Miller FD, Kaplan DR. p63 and p73 coordinate p53 function to determine the balance between survival, cell death, and senescence in adult neural precursor cells. Cell Death Differ 2014; 21:1546-59; PMID:24809925; http://dx.doi.org/10.1038/cdd.2014.61
   PubMed Web of Science ®Google Scholar
• Rosenbluth JM, Pietenpol JA. The jury is in: p73 is a tumor suppressor after all. Genes Dev 2008; 22:2591-5; PMID:18832062; http://dx.doi.org/10.1101/gad.1727408
   PubMed Web of Science ®Google Scholar
• Amelio I, Inoue S, Markert EK, Levine AJ, Knight RA, Mak TW, Melino G. TAp73 opposes tumor angiogenesis by promoting hypoxia-inducible factor 1alpha degradation. Proc Natl Acad Sci U S A 2015; 112:226-31; PMID:25535359; http://dx.doi.org/10.1073/pnas.1410609111
   PubMed Web of Science ®Google Scholar
• Stantic M, Sakil HA, Zirath H, Fang T, Sanz G, Fernandez-Woodbridge A, Marin A, Susanto E, Mak TW, Arsenian Henriksson M, et al. TAp73 suppresses tumor angiogenesis through repression of proangiogenic cytokines and HIF-1alpha activity. Proc Natl Acad Sci U S A 2015; 112:220-5; PMID:25535357; http://dx.doi.org/10.1073/pnas.1421697112
   PubMed Web of Science ®Google Scholar
• Wilhelm MT, Rufini A, Wetzel MK, Tsuchihara K, Inoue S, Tomasini R, Itie-Youten A, Wakeham A, Arsenian-Henriksson M, Melino G, et al. Isoform-specific p73 knockout mice reveal a novel role for delta Np73 in the DNA damage response pathway. Genes Dev 2010; 24:549-60; PMID:20194434; http://dx.doi.org/10.1101/gad.1873910
   PubMed Web of Science ®Google Scholar
• Sayan BS, Yang AL, Conforti F, Tucci P, Piro MC, Browne GJ, Agostini M, Bernardini S, Knight RA, Mak TW, et al. Differential control of TAp73 and DeltaNp73 protein stability by the ring finger ubiquitin ligase PIR2. Proc Natl Acad Sci U S A 2010; 107:12877-82; PMID:20615966; http://dx.doi.org/10.1073/pnas.0911828107
   PubMed Web of Science ®Google Scholar
• Venkatanarayan A, Raulji P, Norton W, Chakravarti D, Coarfa C, Su X, Sandur SK, Ramirez MS, Lee J, Kingsley CV, et al. IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo. Nature 2015; 517:626-30; PMID:25409149; http://dx.doi.org/10.1038/nature13910
   PubMed Web of Science ®Google Scholar
• Di C, Yang L, Zhang H, Ma X, Zhang X, Sun C, Li H, Xu S, An L, Li X, et al. Mechanisms, function and clinical applications of DNp73. Cell Cycle 2013; 12:1861-7; PMID:23708520; http://dx.doi.org/10.4161/cc.24967
   PubMed Web of Science ®Google Scholar
• Fillippovich I, Sorokina N, Gatei M, Haupt Y, Hobson K, Moallem E, Spring K, Mould M, McGuckin MA, Lavin MF, et al. Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53. Oncogene 2001; 20:514-22; PMID:11313982; http://dx.doi.org/10.1038/sj.onc.1204118
   PubMed Web of Science ®Google Scholar
• Stiewe T, Theseling CC, Putzer BM. Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis. J Biol Chem 2002; 277:14177-85; PMID:11844800; http://dx.doi.org/10.1074/jbc.M200480200
   PubMed Web of Science ®Google Scholar
• Stiewe T, Zimmermann S, Frilling A, Esche H, Putzer BM. Transactivation-deficient DeltaTA-p73 acts as an oncogene. Cancer Res 2002; 62:3598-602; PMID:12097259
   PubMed Web of Science ®Google Scholar
• Zaika AI, Slade N, Erster SH, Sansome C, Joseph TW, Pearl M, Chalas E, Moll UM. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. J Exp Med 2002; 196:765-80; PMID:12235210; http://dx.doi.org/10.1084/jem.20020179
   PubMed Web of Science ®Google Scholar
• Killick R, Niklison-Chirou M, Tomasini R, Bano D, Rufini A, Grespi F, Velletri T, Tucci P, Sayan BS, Conforti F, et al. p73: a multifunctional protein in neurobiology. Mol Neurobiol 2011; 43:139-46; PMID:21380933; http://dx.doi.org/10.1007/s12035-011-8172-6
   PubMed Web of Science ®Google Scholar
• Agostini M, Tucci P, Killick R, Candi E, Sayan BS, Rivetti di Val Cervo P, Nicotera P, McKeon F, Knight RA, Mak TW, et al. Neuronal differentiation by TAp73 is mediated by microRNA-34a regulation of synaptic protein targets. Proc Natl Acad Sci U S A 2011; 108:21093-8; PMID:22160687; http://dx.doi.org/10.1073/pnas.1112061109
   PubMed Web of Science ®Google Scholar
• Alexandrova EM, Talos F, Moll UM. p73 is dispensable for commitment to neural stem cell fate, but is essential for neural stem cell maintenance and for blocking premature differentiation. Cell Death Differ 2013; 20:368; PMID:23099852; http://dx.doi.org/10.1038/cdd.2012.134
   PubMed Web of Science ®Google Scholar
• Niklison-Chirou MV, Steinert JR, Agostini M, Knight RA, Dinsdale D, Cattaneo A, Mak TW, Melino G. TAp73 knockout mice show morphological and functional nervous system defects associated with loss of p75 neurotrophin receptor. Proc Natl Acad Sci U S A 2013; 110:18952-7; PMID:24190996; http://dx.doi.org/10.1073/pnas.1221172110
   PubMed Web of Science ®Google Scholar
• Jeong K, Kim H, Kim K, Kim SJ, Hahn BS, Jahng GH, Yoon KS, Kim SS, Ha J, Kang I, et al. Cyclophilin B is involved in p300-mediated degradation of CHOP in tumor cell adaptation to hypoxia. Cell Death Differ 2014; 21:438-50; PMID:24270407; http://dx.doi.org/10.1038/cdd.2013.164
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998; 394:485-90; PMID:9697772; http://dx.doi.org/10.1038/28867
   PubMed Web of Science ®Google Scholar
• Leek RD, Talks KL, Pezzella F, Turley H, Campo L, Brown NS, Bicknell R, Taylor M, Gatter KC, Harris AL. Relation of hypoxia-inducible factor-2 α (HIF-2 α) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in Human breast cancer. Cancer Res 2002; 62:1326-9; PMID:11888900
   PubMed Web of Science ®Google Scholar
• Vincent KA, Feron O, Kelly RA. Harnessing the response to tissue hypoxia: HIF-1 α and therapeutic angiogenesis. Trends Cardiovasc Med 2002; 12:362-7; PMID:12536123; http://dx.doi.org/10.1016/S1050-1738(02)00186-X
   PubMed Web of Science ®Google Scholar
• Krick S, Hanze J, Eul B, Savai R, Seay U, Grimminger F, Lohmeyer J, Klepetko W, Seeger W, Rose F. Hypoxia-driven proliferation of human pulmonary artery fibroblasts: cross-talk between HIF-1alpha and an autocrine angiotensin system. FASEB J 2005; 19:857-9; PMID:15718424
   PubMed Web of Science ®Google Scholar
• Sun CL, Kim E, Crowder CM. Delayed innocent bystander cell death following hypoxia in Caenorhabditis elegans. Cell Death Differ 2014; 21:557-67; PMID:24317200; http://dx.doi.org/10.1038/cdd.2013.176
   PubMed Web of Science ®Google Scholar
• Feng Y, Zhu M, Dangelmajer S, Lee YM, Wijesekera O, Castellanos CX, Denduluri A, Chaichana KL, Li Q, Zhang H, et al. Hypoxia-cultured human adipose-derived mesenchymal stem cells are non-oncogenic and have enhanced viability, motility, and tropism to brain cancer. Cell Death Dis 2014; 5:e1567; PMID:25501828; http://dx.doi.org/10.1038/cddis.2014.521
   PubMed Web of Science ®Google Scholar
• Gordan JD, Bertout JA, Hu CJ, Diehl JA, Simon MC. HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell 2007; 11:335-47; PMID:17418410; http://dx.doi.org/10.1016/j.ccr.2007.02.006
   PubMed Web of Science ®Google Scholar
• Chen Q, Xu J, Li L, Li H, Mao S, Zhang F, Zen K, Zhang CY, Zhang Q. MicroRNA-23a/b and microRNA-27a/b suppress Apaf-1 protein and alleviate hypoxia-induced neuronal apoptosis. Cell Death Dis 2014; 5:e1132; PMID:24651435; http://dx.doi.org/10.1038/cddis.2014.92
   PubMed Web of Science ®Google Scholar
• Gordan JD, Thompson CB, Simon MC. HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell 2007; 12:108-13; PMID:17692803; http://dx.doi.org/10.1016/j.ccr.2007.07.006
   PubMed Web of Science ®Google Scholar
• Luther J, Ubieta K, Hannemann N, Jimenez M, Garcia M, Zech C, Schett G, Wagner EF, Bozec A. Fra-2/AP-1 controls adipocyte differentiation and survival by regulating PPARgamma and hypoxia. Cell Death Differ 2014; 21:655-64; PMID:24464219; http://dx.doi.org/10.1038/cdd.2013.198
   PubMed Web of Science ®Google Scholar
• Chen L, Qiu JH, Zhang LL, Luo XD. Adrenomedullin promotes human endothelial cell proliferation via HIF-1alpha. Mol Cell Biochem 2012; 365:263-73; PMID:22406979; http://dx.doi.org/10.1007/s11010-012-1267-1
   PubMed Web of Science ®Google Scholar
• Volm M, Koomagi R. Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. Anticancer Res 2000; 20:1527-33; PMID:10928066
   PubMed Web of Science ®Google Scholar
• Raz S, Sheban D, Gonen N, Stark M, Berman B, Assaraf YG. Severe hypoxia induces complete antifolate resistance in carcinoma cells due to cell cycle arrest. Cell Death Dis 2014; 5:e1067; PMID:24556682; http://dx.doi.org/10.1038/cddis.2014.39
   PubMed Web of Science ®Google Scholar
• Huang CY, Kuo WT, Huang YC, Lee TC, Yu LC. Resistance to hypoxia-induced necroptosis is conferred by glycolytic pyruvate scavenging of mitochondrial superoxide in colorectal cancer cells. Cell Death Dis 2013; 4:e622; PMID:23640464; http://dx.doi.org/10.1038/cddis.2013.149
   PubMed Web of Science ®Google Scholar
• Son TW, Yun SP, Yong MS, Seo BN, Ryu JM, Youn HY, Oh YM, Han HJ. Netrin-1 protects hypoxia-induced mitochondrial apoptosis through HSP27 expression via DCC- and integrin alpha6beta4-dependent Akt, GSK-3beta, and HSF-1 in mesenchymal stem cells. Cell Death Dis 2013; 4:e563; PMID:23538444; http://dx.doi.org/10.1038/cddis.2013.94
   PubMed Web of Science ®Google Scholar
• Koivunen P, Hirsila M, Remes AM, Hassinen IE, Kivirikko KI, Myllyharju J. Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. J Biol Chem 2007; 282:4524-32; PMID:17182618; http://dx.doi.org/10.1074/jbc.M610415200
   PubMed Web of Science ®Google Scholar
• Esteban MA, Maxwell PH. HIF, a missing link between metabolism and cancer. Nat Med 2005; 11:1047-8; PMID:16211034; http://dx.doi.org/10.1038/nm1005-1047
   PubMed Web of Science ®Google Scholar
• Lall R, Ganapathy S, Yang M, Xiao S, Xu T, Su H, Shadfan M, Asara JM, Ha CS, Ben-Sahra I, et al. Low-dose radiation exposure induces a HIF-1-mediated adaptive and protective metabolic response. Cell Death Differ 2014; 21:836-44; PMID:24583639; http://dx.doi.org/10.1038/cdd.2014.24
   PubMed Web of Science ®Google Scholar
• Guo K, Searfoss G, Krolikowski D, Pagnoni M, Franks C, Clark K, Yu KT, Jaye M, Ivashchenko Y. Hypoxia induces the expression of the pro-apoptotic gene BNIP3. Cell Death Differ 2001; 8:367-76; PMID:11550088; http://dx.doi.org/10.1038/sj.cdd.4400810
   PubMed Web of Science ®Google Scholar
• Kothari S, Cizeau J, McMillan-Ward E, Israels SJ, Bailes M, Ens K, Kirshenbaum LA, Gibson SB. BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF. Oncogene 2003; 22:4734-44; PMID:12879018; http://dx.doi.org/10.1038/sj.onc.1206666
   PubMed Web of Science ®Google Scholar
• Maes H, Van Eygen S, Krysko DV, Vandenabeele P, Nys K, Rillaerts K, Garg AD, Verfaillie T, Agostinis P. BNIP3 supports melanoma cell migration and vasculogenic mimicry by orchestrating the actin cytoskeleton. Cell Death Dis 2014; 5:e1127; PMID:24625986; http://dx.doi.org/10.1038/cddis.2014.94
   PubMed Web of Science ®Google Scholar
• Fan Q, Gao F, Zhang L, Christopher TA, Lopez BL, Ma XL. Nitrate tolerance aggravates postischemic myocardial apoptosis and impairs cardiac functional recovery after ischemia. Apoptosis 2005; 10:1235-42; PMID:16215686; http://dx.doi.org/10.1007/s10495-005-1455-5
   PubMed Web of Science ®Google Scholar
• Roberts DJ, Miyamoto S. Hexokinase II integrates energy metabolism and cellular protection: Akting on mitochondria and TORCing to autophagy. Cell Death Differ 2015; 22:248-57; PMID:25323588; http://dx.doi.org/10.1038/cdd.2014.173
   PubMed Web of Science ®Google Scholar
• Diwan A, Krenz M, Syed FM, Wansapura J, Ren X, Koesters AG, Li H, Kirshenbaum LA, Hahn HS, Robbins J, et al. Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice. J Clin Invest 2007; 117:2825-33; PMID:17909626; http://dx.doi.org/10.1172/JCI32490
   PubMed Web of Science ®Google Scholar
• Seo Y, Ji YW, Lee SM, Shim J, Noh H, Yeo A, Park C, Park MS, Chang EJ, Lee HK. Activation of HIF-1alpha (hypoxia inducible factor-1alpha) prevents dry eye-induced acinar cell death in the lacrimal gland. Cell Death Dis 2014; 5:e1309; PMID:24967971; http://dx.doi.org/10.1038/cddis.2014.260
   PubMed Web of Science ®Google Scholar
• Bianchi P, Kunduzova O, Masini E, Cambon C, Bani D, Raimondi L, Seguelas MH, Nistri S, Colucci W, Leducq N, et al. Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury. Circulation 2005; 112:3297-305; PMID:16286591; http://dx.doi.org/10.1161/CIRCULATIONAHA.104.528133
   PubMed Web of Science ®Google Scholar
• Qi Y, Liu J, Saadat S, Tian X, Han Y, Fong GH, Pandolfi PP, Lee LY, Li S. PTEN induces apoptosis and cavitation via HIF-2-dependent Bnip3 upregulation during epithelial lumen formation. Cell Death Differ 2015; 22(5):875-84.
   Web of Science ®Google Scholar
• Boyd JM, Malstrom S, Subramanian T, Venkatesh LK, Schaeper U, Elangovan B, D'Sa-Eipper C, Chinnadurai G. Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell 1994; 79:341-51; PMID:7954800; http://dx.doi.org/10.1016/0092-8674(94)90202-X
   PubMed Web of Science ®Google Scholar
• Schmidt-Kastner R, Aguirre-Chen C, Kietzmann T, Saul I, Busto R, Ginsberg MD. Nuclear localization of the hypoxia-regulated pro-apoptotic protein BNIP3 after global brain ischemia in the rat hippocampus. Brain Res 2004; 1001:133-42; PMID:14972662; http://dx.doi.org/10.1016/j.brainres.2003.11.065
   PubMed Web of Science ®Google Scholar
• Burton TR, Eisenstat DD, Gibson SB. BNIP3 (Bcl-2 19 kDa interacting protein) acts as transcriptional repressor of apoptosis-inducing factor expression preventing cell death in human malignant gliomas. J Neurosci 2009; 29:4189-99; PMID:19339613; http://dx.doi.org/10.1523/JNEUROSCI.5747-08.2009
   PubMed Web of Science ®Google Scholar
• Hanna RA, Quinsay MN, Orogo AM, Giang K, Rikka S, Gustafsson AB. Microtubule-associated protein 1 light chain 3 (LC3) interacts with Bnip3 protein to selectively remove endoplasmic reticulum and mitochondria via autophagy. J Biol Chem 2012; 287:19094-104; PMID:22505714; http://dx.doi.org/10.1074/jbc.M111.322933
   PubMed Web of Science ®Google Scholar
• Quinsay MN, Thomas RL, Lee Y, Gustafsson AB. Bnip3-mediated mitochondrial autophagy is independent of the mitochondrial permeability transition pore. Autophagy 2010; 6:855-62; PMID:20668412; http://dx.doi.org/10.4161/auto.6.7.13005
   PubMed Web of Science ®Google Scholar
• Kubli DA, Ycaza JE, Gustafsson AB. Bnip3 mediates mitochondrial dysfunction and cell death through Bax and Bak. Biochem J 2007; 405:407-15; PMID:17447897; http://dx.doi.org/10.1042/BJ20070319
   PubMed Web of Science ®Google Scholar
• Burton TR, Henson ES, Azad MB, Brown M, Eisenstat DD, Gibson SB. BNIP3 acts as transcriptional repressor of death receptor-5 expression and prevents TRAIL-induced cell death in gliomas. Cell Death Dis 2013; 4:e587; PMID:23579274; http://dx.doi.org/10.1038/cddis.2013.100
   PubMed Web of Science ®Google Scholar
• Feng X, Liu X, Zhang W, Xiao W. p53 directly suppresses BNIP3 expression to protect against hypoxia-induced cell death. EMBO J 2011; 30:3397-415; PMID:21792176; http://dx.doi.org/10.1038/emboj.2011.248
   PubMed Web of Science ®Google Scholar
• Tomasini R, Tsuchihara K, Wilhelm M, Fujitani M, Rufini A, Cheung CC, Khan F, Itie-Youten A, Wakeham A, Tsao MS, et al. TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev 2008; 22:2677-91; PMID:18805989; http://dx.doi.org/10.1101/gad.1695308
   PubMed Web of Science ®Google Scholar
• Flores ER, Sengupta S, Miller JB, Newman JJ, Bronson R, Crowley D, Yang A, McKeon F, Jacks T. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cancer Cell 2005; 7:363-73; PMID:15837625; http://dx.doi.org/10.1016/j.ccr.2005.02.019
   PubMed Web of Science ®Google Scholar
• Vakkila J, Lotze MT. Inflammation and necrosis promote tumour growth. Nat Rev Immunol 2004; 4:641-8; PMID:15286730; http://dx.doi.org/10.1038/nri1415
   PubMed Web of Science ®Google Scholar
• Rosenfeldt MT, Ryan KM. The role of autophagy in tumour development and cancer therapy. Expert Rev Mol Med 2009; 11:e36; PMID:19951459; http://dx.doi.org/10.1017/S1462399409001306
   PubMed Web of Science ®Google Scholar
• Peng X, Gong F, Chen Y, Jiang Y, Liu J, Yu M, Zhang S, Wang M, Xiao G, Liao H. Autophagy promotes paclitaxel resistance of cervical cancer cells: involvement of Warburg effect activated hypoxia-induced factor 1-α-mediated signaling. Cell Death Dis 2014; 5:e1367; PMID:25118927; http://dx.doi.org/10.1038/cddis.2014.297
   PubMed Web of Science ®Google Scholar
• Amelio I, Melino G, Knight RA. Cell death pathology: cross-talk with autophagy and its clinical implications. Biochem Biophys Res Commun 2011; 414:277-81; PMID:21963447; http://dx.doi.org/10.1016/j.bbrc.2011.09.080
   PubMed Web of Science ®Google Scholar
• Liu K, Shi Y, Guo X, Wang S, Ouyang Y, Hao M, Liu D, Qiao L, Li N, Zheng J, et al. CHOP mediates ASPP2-induced autophagic apoptosis in hepatoma cells by releasing Beclin-1 from Bcl-2 and inducing nuclear translocation of Bcl-2. Cell Death Dis 2014; 5:e1323; PMID:25032846; http://dx.doi.org/10.1038/cddis.2014.276
   PubMed Web of Science ®Google Scholar
• Mathew R, Karantza-Wadsworth V, White E. Role of autophagy in cancer. Nat Rev Cancer 2007; 7:961-7; PMID:17972889; http://dx.doi.org/10.1038/nrc2254
   PubMed Web of Science ®Google Scholar
• Ashrafi G, Schwarz TL. The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ 2013; 20:31-42; PMID:22743996; http://dx.doi.org/10.1038/cdd.2012.81
   PubMed Web of Science ®Google Scholar
• Liu T, Roh SE, Woo JA, Ryu H, Kang DE. Cooperative role of RanBP9 and P73 in mitochondria-mediated apoptosis. Cell Death Dis 2013; 4:e476; PMID:23348590; http://dx.doi.org/10.1038/cddis.2012.203
   PubMed Web of Science ®Google Scholar
• Rufini A, Niklison-Chirou MV, Inoue S, Tomasini R, Harris IS, Marino A, Federici M, Dinsdale D, Knight RA, Melino G, et al. TAp73 depletion accelerates aging through metabolic dysregulation. Genes Dev 2012; 26:2009-14; PMID:22987635; http://dx.doi.org/10.1101/gad.197640.112
   PubMed Web of Science ®Google Scholar
• He Z, Liu H, Agostini M, Yousefi S, Perren A, Tschan MP, Mak TW, Melino G, Simon HU. p73 regulates autophagy and hepatocellular lipid metabolism through a transcriptional activation of the ATG5 gene. Cell Death Differ 2013; 20:1415-24; PMID:23912709; http://dx.doi.org/10.1038/cdd.2013.104
   PubMed Web of Science ®Google Scholar
• Sayan AE, Sayan BS, Gogvadze V, Dinsdale D, Nyman U, Hansen TM, Zhivotovsky B, Cohen GM, Knight RA, Melino G. P73 and caspase-cleaved p73 fragments localize to mitochondria and augment TRAIL-induced apoptosis. Oncogene 2008; 27:4363-72; PMID:18362891; http://dx.doi.org/10.1038/onc.2008.64
   PubMed Web of Science ®Google Scholar
• Adamovich Y, Adler J, Meltser V, Reuven N, Shaul Y. AMPK couples p73 with p53 in cell fate decision. Cell Death Differ 2014; 21:1451-9; PMID:24874608; http://dx.doi.org/10.1038/cdd.2014.60
   PubMed Web of Science ®Google Scholar
• Su X, Gi YJ, Chakravarti D, Chan IL, Zhang A, Xia X, Tsai KY, Flores ER. TAp63 is a master transcriptional regulator of lipid and glucose metabolism. Cell Metabol 2012; 16:511-25; PMID:23040072; http://dx.doi.org/10.1016/j.cmet.2012.09.006
   PubMed Web of Science ®Google Scholar
• Sahin E, DePinho RA. Axis of ageing: telomeres, p53 and mitochondria. Nat Rev Mol Cell Biol 2012; 13:397-404; PMID:22588366; http://dx.doi.org/10.1038/nrm3352
   PubMed Web of Science ®Google Scholar
• Zhao Y, Chaiswing L, Velez JM, Batinic-Haberle I, Colburn NH, Oberley TD, St Clair DK. p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase. Cancer Res 2005; 65:3745-50; PMID:15867370; http://dx.doi.org/10.1158/0008-5472.CAN-04-3835
   PubMed Web of Science ®Google Scholar
• Bergeaud M, Mathieu L, Guillaume A, Moll UM, Mignotte B, Le Floch N, Vayssiere JL, Rincheval V. Mitochondrial p53 mediates a transcription-independent regulation of cell respiration and interacts with the mitochondrial F(1)F0-ATP synthase. Cell Cycle 2013; 12:2781-93; PMID:23966169; http://dx.doi.org/10.4161/cc.25870
   PubMed Web of Science ®Google Scholar
• Amelio I, Antonov AA, Catani MV, Massoud R, Bernassola F, Knight RA, Melino G, Rufini A. TAp73 promotes anabolism. Oncotarget 2014; 5:12820-934; PMID:25514460
   PubMed Web of Science ®Google Scholar
• Amelio I, Markert EK, Rufini A, Antonov AV, Sayan BS, Tucci P, Agostini M, Mineo TC, Levine AJ, Melino G. p73 regulates serine biosynthesis in cancer. Oncogene 2014; 33:5039-46; PMID:24186203; http://dx.doi.org/10.1038/onc.2013.456
   PubMed Web of Science ®Google Scholar
• D'Alessandro A, Amelio I, Berkers CR, Antonov A, Vousden KH, Melino G, Zolla L. Metabolic effect of TAp63alpha: enhanced glycolysis and pentose phosphate pathway, resulting in increased antioxidant defense. Oncotarget 2014; 5:7722-33; PMID:25229745
   PubMed Web of Science ®Google Scholar
• Levine AJ, Puzio-Kuter AM. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 2010; 330:1340-4; PMID:21127244; http://dx.doi.org/10.1126/science.1193494
   PubMed Web of Science ®Google Scholar
• Pan LZ, Ahn DG, Sharif T, Clements D, Gujar SA, Lee PW. The NAD+ synthesizing enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) is a p53 downstream target. Cell Cycle 2014; 13:1041-8; PMID:24552824; http://dx.doi.org/10.4161/cc.28128
   PubMed Web of Science ®Google Scholar
• Pfister NT, Yoh KE, Prives C. p53, DNA damage, and NAD+ homeostasis. Cell Cycle 2014; 13:1661-2; PMID:24810733; http://dx.doi.org/10.4161/cc.29151
   PubMed Web of Science ®Google Scholar
• Velletri T, Romeo F, Tucci P, Peschiaroli A, Annicchiarico-Petruzzelli M, Niklison-Chirou MV, Amelio I, Knight RA, Mak TW, Melino G, et al. GLS2 is transcriptionally regulated by p73 and contributes to neuronal differentiation. Cell Cycle 2013; 12:3564-73; PMID:24121663; http://dx.doi.org/10.4161/cc.26771
   PubMed Web of Science ®Google Scholar
• Giacobbe A, Bongiorno-Borbone L, Bernassola F, Terrinoni A, Markert EK, Levine AJ, Feng Z, Agostini M, Zolla L, Agro AF, et al. p63 regulates glutaminase 2 expression. Cell Cycle 2013; 12:1395-405; PMID:23574722; http://dx.doi.org/10.4161/cc.24478
   PubMed Web of Science ®Google Scholar
• Kostecka A, Sznarkowska A, Meller K, Acedo P, Shi Y, Mohammad Sakil HA, Kawiak A, Lion M, Krolicka A, Wilhelm M, et al. JNK-NQO1 axis drives TAp73-mediated tumor suppression upon oxidative and proteasomal stress. Cell Death Dis 2014; 5:e1484; PMID:25341038; http://dx.doi.org/10.1038/cddis.2014.408
   PubMed Web of Science ®Google Scholar
• He Z, Simon HU. A novel link between p53 and ROS. Cell Cycle 2013; 12:201-2; PMID:23287470; http://dx.doi.org/10.4161/cc.23418
   PubMed Web of Science ®Google Scholar
• Antonov AV. BioProfiling.de: analytical web portal for high-throughput cell biology. Nucleic Acids Res 2011; 39:W323-7; PMID:21609949; http://dx.doi.org/10.1093/nar/gkr372
   PubMed Web of Science ®Google Scholar
• Dietmann S, Lee W, Wong P, Rodchenkov I, Antonov AV. CCancer: a bird's eye view on gene lists reported in cancer-related studies. Nucleic Acids Res 2010; 38:W118-23; PMID:20529879; http://dx.doi.org/10.1093/nar/gkq515
   PubMed Web of Science ®Google Scholar